04:53 PM EDT, 03/28/2025 (MT Newswires) -- OptimizeRx ( OPRX ) on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $75 million in securities from time to time in one or more offerings.

The filing covers common stock, preferred stock, debt securities, warrants, and units.

The company intends to use the proceeds primarily for working capital and general corporate purposes.